These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 12476435)
1. Congress report of the seventh international meeting on psychosocial aspects of genetic testing for hereditary breast and/or ovarian cancer (HBOC) and hereditary non-polyposis colorectal cancer (HNPCC). Jordan J; Evans G; Evers-Kiebooms G; Julian-Reynier C; Kash K; Watson M Psychooncology; 2002; 11(6):536-9. PubMed ID: 12476435 [No Abstract] [Full Text] [Related]
2. Psychosocial aspects of genetic testing for hereditary breast and/or ovarian cancer, 5th international meeting. Leuven, Belgium, June 29-30, 1998. Abstracts. Genet Couns; 1998; 9(4):319-326. PubMed ID: 10206652 [No Abstract] [Full Text] [Related]
3. Development and pilot testing of two decision aids for individuals considering genetic testing for cancer risk. Wakefield CE; Meiser B; Homewood J; Peate M; Kirk J; Warner B; Lobb E; Gaff C; Tucker K J Genet Couns; 2007 Jun; 16(3):325-39. PubMed ID: 17318456 [TBL] [Abstract][Full Text] [Related]
4. Psychological distress in women at risk of hereditary breast/ovarian or HNPCC cancers in the absence of demonstrated mutations. Geirdal AØ; Reichelt JG; Dahl AA; Heimdal K; Maehle L; Stormorken A; Møller P Fam Cancer; 2005; 4(2):121-6. PubMed ID: 15951962 [TBL] [Abstract][Full Text] [Related]
5. The relationship between psychological distress and personality in women from families with familial breast/ovarian or hereditary non-polyposis colorectal cancer in the absence of demonstrated mutations. Geirdal AØ; Dahl AA J Genet Couns; 2008 Aug; 17(4):384-93. PubMed ID: 18607701 [TBL] [Abstract][Full Text] [Related]
6. Comparison of motivations and concerns for genetic testing in hereditary colorectal and breast cancer syndromes. Balmaña J; Stoffel EM; Emmons KM; Garber JE; Syngal S J Med Genet; 2004 Apr; 41(4):e44. PubMed ID: 15060120 [No Abstract] [Full Text] [Related]
7. Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Meiser B Psychooncology; 2005 Dec; 14(12):1060-74. PubMed ID: 15937976 [TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer survivors undergoing genetic testing for hereditary non-polyposis colorectal cancer: motivational factors and psychosocial functioning. Esplen MJ; Madlensky L; Aronson M; Rothenmund H; Gallinger S; Butler K; Toner B; Wong J; Manno M; McLaughlin J Clin Genet; 2007 Nov; 72(5):394-401. PubMed ID: 17892499 [TBL] [Abstract][Full Text] [Related]
9. [Genetic predisposition and ovarian cancer]. Coupier I; Gauthier-Villars M; This P; Stoppa-Lyonnet D Rev Prat; 2004 Oct; 54(16):1757-62. PubMed ID: 15630879 [TBL] [Abstract][Full Text] [Related]
10. Congress report of the Sixth International Meeting on Psychosocial Aspects of Hereditary Breast/Ovarian Cancer Genetic Testing. Julian-Reynier C; Evers-Kiebooms G; Evans G; Zoeteweij M; Moatti JP; Watson M Psychooncology; 2000; 9(6):549-51. PubMed ID: 11180590 [No Abstract] [Full Text] [Related]
11. Genetic profiles distinguish different types of hereditary ovarian cancer. Domanska K; Malander S; Staaf J; Karlsson A; Borg A; Jönsson G; Nilbert M Oncol Rep; 2010 Oct; 24(4):885-95. PubMed ID: 20811668 [TBL] [Abstract][Full Text] [Related]
12. Challenges and Opportunities for Cancer Predisposition Cascade Screening for Hereditary Breast and Ovarian Cancer and Lynch Syndrome in Switzerland: Findings from an International Workshop. Nikolaidis C; Ming C; Pedrazzani C; van der Horst T; Kaiser-Grolimund A; Ademi Z; Bührer-Landolt R; Bürki N; Caiata-Zufferey M; Champion V; Chappuis PO; Kohler C; Erlanger TE; Graffeo R; Hampel H; Heinimann K; Heinzelmann-Schwarz V; Kurzeder C; Monnerat C; Northouse LL; Pagani O; Probst-Hensch N; Rabaglio M; Schoenau E; Sijbrands EJG; Taborelli M; Urech C; Viassolo V; Wieser S; Katapodi MC; Public Health Genomics; 2018; 21(3-4):121-132. PubMed ID: 30695780 [TBL] [Abstract][Full Text] [Related]
13. Effect on a Dutch family of predictive DNA-testing for hereditary breast and ovarian cancer. de Wit AC; Meijers-Heijboer EJ; Tibben A; Frets PG; Klijn JG; Devilee P; Niermeijer MF Lancet; 1994 Jul; 344(8916):197. PubMed ID: 7912795 [No Abstract] [Full Text] [Related]
14. Hereditary cancer-associated mutations in women diagnosed with two primary cancers: an opportunity to identify hereditary cancer syndromes after the first cancer diagnosis. Saam J; Moyes K; Landon M; Williams K; Kaldate RR; Arnell C; Wenstrup R Oncology; 2015; 88(4):226-33. PubMed ID: 25503195 [TBL] [Abstract][Full Text] [Related]
15. Psychosocial aspects of familial breast and ovarian cancer: psychological guidelines for genetic testing. Decruyenaere M; Evers-Kiebooms G; Claes E; Denayer L; Welkenhuysen M; Legius E; Demyttenaere K Dis Markers; 1999 Oct; 15(1-3):152-3. PubMed ID: 10595271 [No Abstract] [Full Text] [Related]
17. Genetic predictive testing for bowel cancer predisposition: the impact on the individual. Chapman PD; Burn J Cytogenet Cell Genet; 1999; 86(2):118-24. PubMed ID: 10545701 [TBL] [Abstract][Full Text] [Related]
18. Information processing in the context of genetic risk: implications for genetic-risk communication. Etchegary H; Perrier C J Genet Couns; 2007 Aug; 16(4):419-32. PubMed ID: 17473961 [TBL] [Abstract][Full Text] [Related]
19. [Psychosocial aspects of predictive gene diagnosis in familial breast and ovarian carcinomas]. von der Groeben C; Neef K; Rohde A; Bodden-Heidrich R; Schmutzler RK Dtsch Med Wochenschr; 1999 Mar; 124(12):361-2. PubMed ID: 10214370 [No Abstract] [Full Text] [Related]
20. Attitudes toward genetic testing for cancer risk after genetic counseling and decision support: a qualitative comparison between hereditary cancer types. Wakefield CE; Kasparian NA; Meiser B; Homewood J; Kirk J; Tucker K Genet Test; 2007; 11(4):401-11. PubMed ID: 18294057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]